AU2001234174A1 - Phosphonate nucleotide compound - Google Patents
Phosphonate nucleotide compoundInfo
- Publication number
- AU2001234174A1 AU2001234174A1 AU2001234174A AU3417401A AU2001234174A1 AU 2001234174 A1 AU2001234174 A1 AU 2001234174A1 AU 2001234174 A AU2001234174 A AU 2001234174A AU 3417401 A AU3417401 A AU 3417401A AU 2001234174 A1 AU2001234174 A1 AU 2001234174A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleotide compound
- phosphonate nucleotide
- phosphonate
- compound
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Phosphonate nucleotide compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000054675 | 2000-02-29 | ||
JP2000-54675 | 2000-02-29 | ||
PCT/JP2001/001412 WO2001064693A1 (fr) | 2000-02-29 | 2001-02-26 | Compose de nucleotide de phosphonate |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001234174A1 true AU2001234174A1 (en) | 2001-09-12 |
Family
ID=18575897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001234174A Abandoned AU2001234174A1 (en) | 2000-02-29 | 2001-02-26 | Phosphonate nucleotide compound |
Country Status (5)
Country | Link |
---|---|
US (1) | US6767900B2 (ko) |
KR (1) | KR20020093824A (ko) |
CN (1) | CN1426418A (ko) |
AU (1) | AU2001234174A1 (ko) |
WO (1) | WO2001064693A1 (ko) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003028737A1 (en) * | 2001-08-30 | 2003-04-10 | Mitsubishi Pharma Corporation | Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon |
US20050239054A1 (en) * | 2002-04-26 | 2005-10-27 | Arimilli Murty N | Method and compositions for identifying anti-HIV therapeutic compounds |
EA008775B1 (ru) | 2002-04-26 | 2007-08-31 | Джилид Сайэнс, Инк. | Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция |
AU2003242428A1 (en) * | 2002-05-24 | 2003-12-12 | Mitsubishi Pharma Corporation | Drugs improved in tissue selectivity |
US7452901B2 (en) * | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
JP2006524710A (ja) * | 2003-04-25 | 2006-11-02 | ギリアード サイエンシーズ, インコーポレイテッド | キナーゼインヒビターホスホネート抱合体 |
US7300924B2 (en) * | 2003-04-25 | 2007-11-27 | Gilead Sciences, Inc. | Anti-infective phosphonate analogs |
CN101410120A (zh) * | 2003-04-25 | 2009-04-15 | 吉里德科学公司 | 抗炎的膦酸酯化合物 |
DK1628685T3 (da) * | 2003-04-25 | 2011-03-21 | Gilead Sciences Inc | Antivirale phosphonatanaloge |
US20050261237A1 (en) * | 2003-04-25 | 2005-11-24 | Boojamra Constantine G | Nucleoside phosphonate analogs |
US7432261B2 (en) * | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
WO2005002626A2 (en) * | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
US20090247488A1 (en) * | 2003-04-25 | 2009-10-01 | Carina Cannizzaro | Anti-inflammatory phosphonate compounds |
US7470724B2 (en) * | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
US7407965B2 (en) * | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
WO2004096287A2 (en) * | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
WO2005044279A1 (en) * | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Purine nucleoside phosphonate conjugates |
WO2005044308A1 (en) * | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
JP2007508843A (ja) | 2003-10-24 | 2007-04-12 | ギリアード サイエンシーズ, インコーポレイテッド | 治療用化合物の同定のための方法および組成物 |
MXPA06006899A (es) * | 2003-12-22 | 2006-09-04 | Gilead Sciences Inc | Derivados de carbovir y abacavir 4'-sustituidos asi como compuestos relacionados con actividad antiviral de virus de inmunodeficiencia humana y virus de la hepatitis c. |
US20050153990A1 (en) * | 2003-12-22 | 2005-07-14 | Watkins William J. | Phosphonate substituted kinase inhibitors |
US20070281907A1 (en) * | 2003-12-22 | 2007-12-06 | Watkins William J | Kinase Inhibitor Phosphonate Conjugates |
CN100475825C (zh) * | 2004-03-19 | 2009-04-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 无环核苷膦酸酯衍生物 |
US7871991B2 (en) | 2004-07-27 | 2011-01-18 | Gilead Sciences, Inc. | Phosphonate analogs of HIV inhibitor compounds |
CA2585353A1 (en) * | 2004-10-26 | 2006-05-04 | Gilead Sciences, Inc. | Phosphonate derivatives of mycophenolic acid |
ES2401285T3 (es) | 2004-12-16 | 2013-04-18 | The Regents Of The University Of California | Fármacos con el pulmón como diana |
WO2007014491A1 (fr) * | 2005-08-03 | 2007-02-08 | Beijing Fu Kang Ren Bio-Pharm Tech.Co.Ltd. | Phosphonates de nucléotides acycliques et leur utilisation dans des agents antiviraux |
CN1935817B (zh) * | 2005-09-19 | 2011-05-11 | 北京阜康仁生物制药科技有限公司 | 新的无环核苷膦酸酯及其医药用途 |
CN101940571A (zh) | 2007-04-13 | 2011-01-12 | 南方研究所 | 抗血管生成剂和使用方法 |
US8787221B2 (en) * | 2007-10-23 | 2014-07-22 | La Crosse Technology, Ltd. | Method of transmitting, receiving, recording, playing and displaying weather radio |
MX2011000306A (es) * | 2008-07-08 | 2011-03-15 | Gilead Sciences Inc | Sales de compuestos inhibidores de hiv. |
CN102093422B (zh) | 2009-12-10 | 2015-02-25 | 中国人民解放军军事医学科学院毒物药物研究所 | 无环核苷膦酸酯衍生物及其医药用途 |
KR101115041B1 (ko) | 2011-01-07 | 2012-03-06 | 경남과학기술대학교 산학협력단 | 계육 가수분해물을 포함하는 기능성 조성물 및 이의 제조방법 |
DK2794624T3 (da) | 2011-12-22 | 2019-07-22 | Geron Corp | Guanin-analoger som telomerase-substrater og påvirkere af telomer-længde |
CN105246902B (zh) | 2013-03-15 | 2018-05-04 | 加利福尼亚大学董事会 | 无环核苷膦酸二酯 |
KR102589658B1 (ko) | 2014-09-15 | 2023-10-13 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뉴클레오타이드 유사체 |
WO2017048956A1 (en) | 2015-09-15 | 2017-03-23 | The Regents Of The University Of California | Nucleotide analogs |
EP3960740B1 (en) | 2017-08-01 | 2023-11-15 | Gilead Sciences, Inc. | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) vanillate for treating viral infections |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE199906T1 (de) | 1993-06-29 | 2001-04-15 | Mitsubishi Chem Corp | Phosphonat-nukleotid ester-derivate |
CA2195262C (en) | 1996-01-18 | 2005-08-09 | Masaru Ubasawa | Phosphonate nucleotide compounds |
KR20020097384A (ko) * | 2001-06-20 | 2002-12-31 | 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 | 기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제 |
-
2001
- 2001-02-26 AU AU2001234174A patent/AU2001234174A1/en not_active Abandoned
- 2001-02-26 US US10/220,126 patent/US6767900B2/en not_active Expired - Fee Related
- 2001-02-26 KR KR1020027011237A patent/KR20020093824A/ko not_active Application Discontinuation
- 2001-02-26 CN CN01808799A patent/CN1426418A/zh active Pending
- 2001-02-26 WO PCT/JP2001/001412 patent/WO2001064693A1/ja not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20020093824A (ko) | 2002-12-16 |
US20030153534A1 (en) | 2003-08-14 |
CN1426418A (zh) | 2003-06-25 |
US6767900B2 (en) | 2004-07-27 |
WO2001064693A1 (fr) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001234174A1 (en) | Phosphonate nucleotide compound | |
AU2002225730A1 (en) | Compounds | |
AU2002218266A1 (en) | Novel indanylidene compounds | |
AU2001292030A1 (en) | Antiparasitic compounds | |
AU2001292518A1 (en) | Novel compounds | |
AU2001266345A1 (en) | Five-membered-ring compound | |
AU2001265089A1 (en) | Rc-timer scheme | |
AUPQ661800A0 (en) | Insulin-potentiating compounds | |
AU2001239765A1 (en) | Novel compounds | |
AU2001246998A1 (en) | Novel compounds | |
AU2001253362A1 (en) | Novel compounds | |
AU2002231077A1 (en) | Novel compounds | |
EP1277758A4 (en) | PHOSPHORUS COMPOUND | |
AU2001256964A1 (en) | Novel compounds | |
AU2002225724A1 (en) | Motilide compounds | |
AU5935600A (en) | Phosphoramide compounds | |
AU2002220684A1 (en) | Fap-alpha-activated anti-tumor compounds | |
AU2001236065A1 (en) | Antiviral compounds | |
AU2002217285A1 (en) | Compounds | |
AU2001230689A1 (en) | Novel compounds | |
AU2002216060A1 (en) | Novel compounds | |
AU2002221923A1 (en) | Novel compounds | |
AU2001276890A1 (en) | Novel compounds | |
AUPQ575300A0 (en) | New compound | |
AUPR018900A0 (en) | Pamidronate solution |